Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains.
about
Recognition of 5'-terminal TAR structure in human immunodeficiency virus-1 mRNA by eukaryotic translation initiation factor 2.Identification of a minimal region of the HIV-1 5'-leader required for RNA dimerization, NC binding, and packagingStructural determinants and mechanism of HIV-1 genome packagingRobustness and evolvability: a paradox resolvedEfficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidationSecondary structure model of the Mason-Pfizer monkey virus 5' leader sequence: identification of a structural motif common to a variety of retrovirusesPosition dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivoThe human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structuresMg2+ dependency of HIV-1 reverse transcription, inhibition by nucleoside analogues and resistance.Translational Control of the HIV Unspliced Genomic RNAAutomatic detection of conserved RNA structure elements in complete RNA virus genomesSecondary Structure of the 3' Terminus of Hepatitis C Virus Minus-Strand RNACircularization of the HIV-1 RNA genomeThe apical loop of the HIV-1 TAR RNA hairpin is stabilized by a cross-loop base pairInitiation of HIV-1 reverse transcription is regulated by a primer activation signalIn vitro evidence for a long range pseudoknot in the 5'-untranslated and matrix coding regions of HIV-1 genomic RNADirect and indirect contributions of RNA secondary structure elements to the initiation of HIV-1 reverse transcriptionStructure of influenza virus RNP. I. Influenza virus nucleoprotein melts secondary structure in panhandle RNA and exposes the bases to the solventIdentification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitroAntisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cellsInhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNAAn intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA.Neutral network sizes of biological RNA molecules can be computed and are not atypically small.HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell cultureThe nucleocapsid protein specifically anneals tRNALys-3 onto a noncomplementary primer binding site within the HIV-1 RNA genome in vitro.Reverse transcription of a self-primed retrotransposon requires an RNA structure similar to the U5-IR stem-loop of retroviruses.The human immunodeficiency virus type 1 TAR RNA upper stem-loop plays distinct roles in reverse transcription and RNA packaging.Changes in Rous sarcoma virus RNA secondary structure near the primer binding site upon tRNATrp primer annealing.Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.An intact U5-leader stem is important for efficient replication of simian immunodeficiency virus.Two ribosome recruitment sites direct multiple translation events within HIV1 Gag open reading frame.Structural basis for the specificity of the initiation of HIV-1 reverse transcription.Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells.Kinetic analysis of the nucleic acid chaperone activity of the hepatitis C virus core protein.Exciton interaction in molecular beacons: a sensitive sensor for short range modifications of the nucleic acid structure.Excitonic heterodimer formation in an HIV-1 oligonucleotide labeled with a donor-acceptor pair used for fluorescence resonance energy transferConserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicingSingle-molecule FRET studies of important intermediates in the nucleocapsid-protein-chaperoned minus-strand transfer step in HIV-1 reverse transcription.Dimerization of HIV-1 genomic RNA of subtypes A and B: RNA loop structure and magnesium bindingTwo alternating structures of the HIV-1 leader RNA
P2860
Q24515333-8FBCF3F0-1C85-4A58-9AD1-335E41D1CA92Q24622200-BD68E3FC-90FB-49BB-A5C6-93D15B91BD41Q24632055-22AD0274-1B56-43EB-BE3F-DCF4526A4767Q24657364-1473DF13-2A4B-4A70-A3BF-6F2EA18E17A2Q24673792-6D3A2C77-4F27-4A1C-B91B-02B81FC99B79Q24675715-D97B248B-6C2E-474E-B7E1-2AFB3C68541DQ24678656-3A21BDFE-42D4-4F3A-9CE9-E9486E7CA6DDQ24682817-47014EAF-A409-4F4E-9EAA-8416F67EA2C0Q25256746-12D2E163-0265-4D3F-9D25-97E6D99DD3DBQ26801493-737BA27A-05E6-4D2B-B9BD-17645A61E200Q27473247-885B2A52-DA23-4829-9C64-BB052A00F85AQ27473515-A7734AF4-E534-4573-85A2-1BE2E427C4DAQ27481058-A006ABB2-36B8-4740-A888-72FC3F656E6FQ28189849-4F1F59E6-91ED-43CF-9809-951B1BD3790BQ28198193-1B95B755-BC7F-4B87-8161-A1356B43F37CQ28211352-576A494F-61B9-409A-89BB-F33EB1FFCAA2Q28219007-238E6EF3-7811-4B15-A66C-D5D2C06C800BQ28245490-594AB019-36AF-4022-8234-0099ABD5F69BQ28254442-336D5751-1659-4A44-8E1A-B7D77B451C86Q28369354-239008C5-D464-46EE-9A7A-940D218D1720Q28478188-B9FDAF93-3111-4E0F-A185-B9C8FBAF632AQ30303886-320C9245-4DB1-4C6C-B99D-98BFFE097377Q30485948-A5D68D9A-F55D-4335-ACD3-11E91A09766DQ30953558-732BCAFC-B6C2-4C3C-B3D1-AE8561656FDCQ33709362-E54FB7F2-D13A-441A-9637-E22379A55682Q33781614-4C40BD29-C2DF-4477-A444-0930BEB10B67Q33805882-2E75098A-429B-4494-A3A9-84C661BFBC06Q33816547-D75C187A-0A1D-464C-BE0F-711793CA98E8Q33818125-6D650C0B-CA30-464D-BF41-D258A242A2D8Q33850342-55DE09D6-BEB4-459B-AF28-EB165255C658Q33878231-796D6BFF-D131-4549-BD38-1CEF4BD5ADA4Q33890456-F0DA7277-32A5-4988-ACB9-B044DAE6E604Q33903623-27FF78C0-B6AC-425F-BF6B-0D654A8CAC4EQ33922423-5959F0C1-4E0D-4B13-9187-6A6CA0853538Q33940367-29F46BDD-C64E-4D74-9D72-A954353F837EQ34180258-2932741D-28CF-4894-A319-093C26BADB01Q34260427-43C79356-5622-4746-9A4A-B28604722A94Q34351841-323E7233-9CD9-43A5-B6C2-2775B45F0209Q34362112-37373875-3FC2-4079-9BE9-6D5D02EC99B3Q34363290-07D453B0-E7DE-46EB-A203-6CA01392D118
P2860
Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Functional sites in the 5' reg ...... rm defined structural domains.
@en
Functional sites in the 5' reg ...... rm defined structural domains.
@nl
type
label
Functional sites in the 5' reg ...... rm defined structural domains.
@en
Functional sites in the 5' reg ...... rm defined structural domains.
@nl
prefLabel
Functional sites in the 5' reg ...... rm defined structural domains.
@en
Functional sites in the 5' reg ...... rm defined structural domains.
@nl
P2093
P356
P1476
Functional sites in the 5' reg ...... rm defined structural domains.
@en
P2093
P304
P356
10.1006/JMBI.1993.1041
P407
P577
1993-01-01T00:00:00Z